DOI: 10.1055/s-00000097

Deutsche Zeitschrift für Onkologie


von Hagens C, Walter-Sack I, Goeckenjan M. et al.
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2).

Breast Cancer Res Treat 2017;
164: 359-369

Download Bibliographical Data

Search in: